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Abstract: Bifidobacteria commonly constitute the most abundant group of microorganisms in the
healthy infant gut. Their intestinal establishment is believed to be maternally driven, and their
acquisition has even been postulated to occur during pregnancy. In the current study, we evaluated
bifidobacterial mother-to infant transmission events in a rat model by means of quantitative PCR
(qPCR), as well as by Internally Transcribed Spacer (ITS) bifidobacterial profiling. The occurrence of
strains supplied by mothers during pregnancy to their corresponding newborns was observed and
identified by analysis immediately following C-section delivery. These findings provide intriguing
support for the existence of an unknown route to facilitate bifidobacterial transfer during the very
early stages of life.
Keywords: bifidobacteria; infant gut microbiota; microbe-host coevolution; metagenomics
1. Introduction
Bifidobacteria are dominant members of the infant gut microbiota, although their numbers are
known to decrease during weaning and adolescence, with a further decline in relative abundance in
the elderly population [1,2]. Their role as natural modulators of the host immune system, as well as
their impact on the physiology and metabolism of the human large intestine are subject to significant
scientific scrutiny [1,3]. Due to these purported health benefits it is no surprise that bifidobacteria are
frequently incorporated as functional ingredients in various (functional) foods and pharmaceutical
products. Bacterial colonization of the human gut represents a very active field of fundamental and
applied research, where bifidobacteria represent a key target group, and where strategies to influence
the development, composition, and activities of the infant bifidobacterial members of the gut microbiota
by means of nutraceutical products (e.g., probiotics and/or prebiotics) are very topical.
Various publications have described that the first microbial consortia in the gut of newborns
may harbor bacteria that are vertically transmitted from the mother [4–7]. In this context, it has been
discovered that amongst these maternally inherited bacteria, bifidobacteria represent an important
group of gut commensals [8–10]. A recent study focusing on the identification of vertically acquired
bifidobacterial strains based on a combination of shotgun metagenomics data, Internally Transcribed
Spacer (ITS) bifidobacterial profiling analysis and a cultivation approach, described the finding
Microorganisms 2019, 7, 293; doi:10.3390/microorganisms7090293 www.mdpi.com/journal/microorganisms
Microorganisms 2019, 7, 293 2 of 13
of several bifidobacterial strains, including members of the Bifidobacterium breve, Bifidobacterium
longum subsp. longum and Bifidobacterium bifidum species, which were shared between mother-infant
dyads [9]. The identification of vertically transmitted bifidobacterial strains represents a key example
of microbe-host co-evolution, and is a phenomenon that was also identified in other primate and
non-primate mammals, where bifidobacteria were found to be commonly inherited from mother to
her offspring, and where mother’s milk appears to represent an important route to facilitate such
transfer events [11]. Furthermore, a recent study revealed that the composition of human milk is able
to influence the gut microbiota of newborns, with potential implications for infant development and
health [12].
The heretofore accepted dogma that the infant gut is sterile before birth has in recent years been
challenged by different studies which suggest the existence of an intra-uterine and placenta bacterial
community [13–15], though the presence and role of a genuine pre-birth microbiota is still controversial
and subject to debate [14,16,17].
In the current study, we investigated vertical transmission events of bifidobacteria employing an
in vivo model (Rattus norvegicus), resulting in a different bifidobacterial inheritance outcome when
pregnant animals were treated with a single Bifidobacterium strain as compared to a mix of bifidobacterial
strains belonging to three different Bifidobacterium species, i.e., B. bifidum, B. breve and B. longum.
2. Results and Discussion
2.1. Evaluation of Vertical Transmission of Bifidobacteria under in Vivo Conditions
As previously shown by metagenomic attempts, identical bifidobacterial strains have been found
in the fecal samples of mother-newborn dyads [7,9]. In order to evaluate possible microbial transfer
by pregnant rats treated with a bifidobacterial strain mix consisting of B. bifidum PRL2010, B. breve
1895B and B. longum subsp. longum 1886 strains, or rats treated with B. bifidum strain PRL2010 only,
animals were divided in two different groups. The first group consisted of three female rats, which
were treated with the bifidobacterial mix (Mix Colonization Group—MCG), whereas the second group
encompassed nine female rats, to which only PRL2010 was administered (PRL2010 Group—PG).
Notably, the bifidobacterial strains used were, previously, isolated from fecal samples from healthy
breast-fed infants [11,18,19]. However, even if these bacterial strains were not belonging to the
indigenous microbiota of rat, when administered to these animals during pregnancy, they are able to
colonize the gut of rat (see below). A similar result has been described previously by Jimenez et al.,
where a human infant gut commensal, Enterococcus faecium, was able to be vertically transmitted in
pregnant mice.
At the start of the experiment, rats were checked for the presence of strains PRL2010, 1895B and/or
1886B in fecal samples by means of PCR using strain-specific primer pairs, revealing that, as expected,
these bifidobacterial strains were absent in the animals enrolled in this study and prior to them being
fed any of the strains. Dams were administered a daily dose of 109 colony forming units (CFU) of
B. bifidum PRL2010 or a mix of B. bifidum PRL2010, B. longum subsp. longum 1886B and B. breve 1895B
for 21 days. Presence and clearance of B. bifidum PRL2010, B. longum subsp. longum 1886B and B. breve
1895B were monitored during the gestation period using a qPCR approach based on strain-specific
primers (Figure 1). Following Caesarian delivery of the pups, rats were sacrificed and their caecum was
removed and assayed for the presence of PRL2010, 1886B and 1895B by means of qPCR. Interestingly,
the microbial density estimated by qPCR of B. bifidum PRL2010 in the caecal samples of mothers ranged
from 104 to 107 CFU, whereas in caecal samples of pups, the abundance ranged from 103 to 106 CFU
(Figure 1). Similarly, the qPCR estimated abundance of B. breve 1895B in the caecum of mothers and of
newborns ranged from 104 to 107 and 102 to 106, respectively (Figure 1). The cell load determined by
qPCR of B. longum subsp. longum 1886B in the mother’s gut and in pup’s caecum varies from 103 to 107
and 102 to 104, respectively (Figure 1).
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(Mix Colonization Group—MCG). Pa el (a) shows the average of DNA presenc of the three
strains obs rved during the bifidobacterial administration. Each point represe ts the average of
the log-population size ± standard deviation for three rats. Panel (b) displays the presence of
B. breve 1895B, B. bifidum PRL2010 and B. longum subsp. longum 1886B in th caecum of f male rats.
Panel (c) exhibits b fidobacterial retrieval from puppies’ caecum. Each pillar r presents the ave ag
presence for each Bifidobacterium strain ± standard deviation.
In addition, we isolated viable PRL2010/1895B/1897B cells from the caecal samples of the mothers
by means of direct cultivation of caecal contents of animals on mMRS followed by the precise
strain-assig ment of the isolated c lls using a PCR approach based on strain-specific primers.
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2.2. Maternal Inheritance of B. bifidum PRL2010 Strain
Since B. bifidum strain PRL2010 has been shown to represent a model infant gut
commensal [9,18,20–34], and as described above for the Mix Colonization Group—MCG, this strain
displayed the highest level of vertical transmission from mother to newborns, we decided to further
examine the maternal inheritance of strain PRL2010. Bifidobacterial inheritance of nine pregnant
rats receiving a daily dose of 109 CFU of B. bifidum PRL2010 for three weeks was monitored by
qPCR (Figure 2). These rats delivered their puppies by Caesarian section and PRL2010 levels were
evaluated by qPCR using strain-specific primers targeting both the caecal sample of the mother and
the corresponding pups (Figure 2). The estimated abundance of PRL2010 cells by qPCR ranged from
103 to 104 CFU and from 102 to 104 CFU in mother and newborns samples, respectively (Figure 2).
Notably, the PRL2010 colonization was lower in PG mothers respect to MCG mothers (p value < 0.001).
Concurrently, the genome copy number of PRL2010 in the newborns from PG group was lower
respect those observed in MCG newborns group (p value < 0.001). These findings suggest that
microbe-microbe interactions provide an advantage in the vertical transmission efficiency of these
species in the infant gut. In addition, such results corroborate previous data regarding the existence of
syntrophic interactions between bifidobacteria in the infant gut [9,11,33].
However, the bacterial load of PRL2010 in the MCG newborns group resulted lower respect to
their mothers. In contrast, the PG newborns group showed a higher abundance of PRL2010 cells when
compared to their mothers (Figure S2). Probably, the load of B. bifidum PRL2010 cells in the newborns
of PG group is higher respect to their mothers because it has been administered as a mono-strain
supplement. Conversely, the simultaneously supplementation of bifidobacterial mix encompassing
different strains in MCG group contributed to the decreased level of PRL2010 cells in the newborns.
Microorganisms 2019, 7, 293 5 of 13
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Figure 2. Schematic representation of vertical inheritance of B. bifidum strain PRL2010, when
administered solely in a rat model (PRL2010 Group—PG). Panel (a) shows the population sizes
of B. bifidum PRL2010 present in the intestine of female rats. Each point represents the average of
the log-population size ± standard deviation for nine rats. Panel (b) displays the B. bifidum PRL2010
retrieval ± standard deviation for each female rat used. Panel (c) exhibits the presence of B. bifidum
PRL2010 in the caecum from puppies. Each pillar represents the average colonization ± standard
deviation of puppies for each female rat.
2.3. Identification of DNA Belonging o PRL2010 in Different Rat Body Sites
Bifidobacterial DNA occurrence in other body sites of rats such as placenta and blood samples,
which was collected from mothers immediately after Caesarian delivery, was investigated by qPCR
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using PRL2010-specific primers. Remarkably, these experiments revealed the presence of DNA
belonging to PRL2010 in the placental tissue but not in blood (Figure 3). Similar results were described
previously by Jimenez et al. in a trial examining the vertical transmission of E. faecium HA1 in pregnant
mice [35]. Any attempts directed to cultivate PRL2010 cells from placenta samples under mMRS did
not result in the isolation of viable cells. These findings suggest that either the rat placenta can only
be reached by DNA from lysed PRL2010 cells or that this body compartment only contains dormant
PRL2010 cells. These data may also open a novel and intriguing scenario of prenatal colonization of
rats by B. bifidum PRL2010.
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Figure 3. Schematic representation of the B. bifidum PRL2010 DNA load observed in placentas’ samples.
This graphic displays the level of DNA belonging to B. bifidum PRL2010 present in the placenta of
rats. Each pillar represents the average retrieval ± standard deviation of B. bifidum PRL2010 from the
placenta of rats.
2.4. ITS Bifidobacterial Profiling of the Caecum of Mothers and Newborns
In order to further characterize the bifidobacterial composition of caecal samples from mothers
and puppies, ITS bifidobacterial profiling analyses were performed [36] on these 30 samples, producing
a total of 212,034 reads with an aver ge of 7068 ± 6457 reads per ample (Table 1). These raw data
were processed to identify and classify reads into clusters of identical sequences (OTUs). In detail, we
focused our interest on OTUs belonging to the species B. bifidum, B. breve and B. longum subsp. longum.
Interestingly, all puppies of the MCG group shared these three OTUs with the corresponding mothers’
samples (Figure 4). Moreover, a comparison between PG mothers with their corresponding puppies
showed that in 70% of cases the OTUs belonging to the species B. bifidum, B. breve and B. longum subsp.
longum are shared (Figure 4). In order to confirm the presence of B. bifidum, B. breve and B. longum
subsp. longum in PG group, we performed a qPCR using species-specific primers using mothers’ caeca
(Figure 4). These data revealed that B. breve and B. longum subsp. longum species were present in the
gut microbiota of pregnant rats, even if they were not supplemented to the animals (Figure 4).
Microorganisms 2019, 7, 293 7 of 13
Table 1. Filtering table of the analyzed caecal samples.
Experiment Groups Samples Name Input Reads Final Reads
PG W4-mother 3423 3126
PG F4-1 2589 2386
PG F4-2 8551 8012
PG F4-3 4126 3776
PG W6-mother 2078 1970
PG F6-1 2164 2036
PG F6-2 5050 4852
PG W8-mother 1239 1201
PG F8-1 6365 5797
PG F8-2 4527 4050
PG W11-mother 1009 942
PG F11-1 4106 3908
PG F11-2 2133 2036
PG F11-3 1692 1642
MCG W2-mother 22,528 22,026
MCG F2-1 12,703 11,906
MCG F2-2 32,065 29,485
MCG F2-3 11,715 10,850
MCG F2-4 17,106 15,929
MCG F2-5 13,992 12,724
MCG F2-6 10,339 9739
MCG W3-mother 2686 2640
MCG F3-1 4818 4620
MCG F3-2 8970 8489
MCG F3-3 5346 4987
MCG F3-4 5664 5373
MCG F3-5 2765 2584
MCG F3-6 12,523 11,182
MCG F3-7 6129 5701
MCG F3-8 8524 8065
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These results further support the notion of transfer of (bifido)bacterial DNA and/or cells between
mother and puppies [11,37] and reinforced the earlier finding that co-existence of multiple bifidobacterial
species allows a more efficient transmission of (bifido)bacterial DNA and/or cells from mothers to their
newborns [9,11,33].
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3. Materials and Methods
3.1. Experiment Design and Bifidobacterial Treatment of Rats
Experiments were performed in accordance with the European Community Council Directive
2010/63/UE and approved by the Italian legislation on animal experimentation (D.L. 04/04/2014, n. 26,
authorization no. 370/2018-PR). All efforts were made to reduce sample size and minimize animal
suffering. For the purposes of the current study we employed adult (4–6 months) Wistar rats (Rattus
norvegicus) which were bred in house under standard conditions [38,39]. The timeline of animal
treatment procedures is schematically depicted in supplemental Figure S1. The duration of the animal
trial was four weeks in total. Mating was allowed during week 1 and for this purpose, 12 adult
female rats (Rattus norvegicus) were coupled with 12 male rats. Pairs were kept in different cages in
rooms with controlled temperature (22 ± 2 ◦C) and humidity (60 ± 10%) and maintained in a 12/12
light/dark cycle (light on from 19: 00 to 7: 00 h), with food and water ad libitum. Following the one
week mating period, all female rats were separated and kept in individual cages and were every day
orally treated with bifidobacterial strains for three weeks, which represented the gestation period.
One group of three female rats (which are here referred to as W1, W2 and W3) was orally inoculated
with a mix of three different strains, i.e., B. bifidum PRL2010, B. breve 1895B and B. longum subsp.
longum 1886B (Mix Colonization Group–MCG). The second group with the remaining nine female
rats (W4, W5, W6, W7, W8, W9, W10, W11 and W12) was orally treated with B. bifidum PRL2010
only (PRL2010 Group—PG). All the strains used in this study were previously isolated from infant
stool samples [18,19]. In order to evaluate bifidobacterial transfer, fecal samples were collected at five
different time points. The first time point was before the oral administration of bifidobacteria (T0).
Then, we collected fecal samples at four time points, i.e., at five, eight, 12 and 17 days (T1, T2, T3
and T4) (Figure S1). On the 19th day of bifidobacterial treatment (i.e., on the day of birth, but prior to
labor) female animals were anesthetized with isoflurane (2% in 100% oxygen) and Caesarian delivery
was performed under a laminar flow hood and all the surgical instruments used were previously
sterilized in order to prevent any microbial contamination. Placentas were harvested and caecum and
blood samples were collected from dams and pups.
3.2. Bifidobacterium Strains Growth Conditions
All strains used in this study were cultivated in an anaerobic atmosphere (2.99% H2, 17.01%
CO2 and 80% N2) in an anaerobic chamber (Concept 400, Ruskin) on De Man-Rogosa-Sharp (MRS)
broth (Scharlau Chemie, Barcelona, Spain) supplemented with 0.05% (w/v) L-cysteine hydrochloride
(Sigma-Aldrich, Saint Louis, USA) and incubated at 37 ◦C. Microbial cultures were harvested by
centrifugation (3000 rpm for 8 min), washed and resuspended in 500 µL of 2 % (w/v) sucrose solution.
The viable count of each inoculum was determined by retrospective plating on MRS.
3.3. DNA Extraction and qPCR
Bacterial DNA extraction from fecal samples was performed following the manufacturer’s protocol
of the QIAamp Fast DNA stool Mini Kit (Qiagen Ltd., Strasse, Germany). Furthermore, bifidobacterial
DNA presence was evaluated for the mother’s caecum, placentas, blood samples, and from puppies’
caecal samples. Specifically, the bacterial DNA from puppies and mothers’ caecum and from placentas
was extracted following the protocol of Power Viral Environmental RNA/DNA Isolation Kit (Mo Bio,
Hilden, Germany), whereas the bacterial DNA from mother’s blood was extracted following the
protocol of the DNeasy Blood and Tissue Kit (Qiagen Ltd., Strasse, Germany).
Quantitative PCR (qPCR) was performed as described previously [32]. For B. bifidum
PRL2010 were used primers Bbif_0282Fw (5′-GCGAACAATGATGGCACCTA-3′) and Bbif_0282Rv
(5′-GTCGAACACCACGACGATGT-3′) [24], for B. breve 1895B were used primers BBR7E_0534_fw
(5′-AGCGACGATATGATGCAATG-3′) and BBR7E_0534_rev (5′-CGTGAATACGCTGCACAGTC-3′)
and for B. longum subsp. longum 1886B were used primers B1886_0443_fw (5′-AAGCCAAGGACATGTT
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CGAC-3′) and B1886_0443_rev (5′-TGGTGTATCTGGCGTTCTTG-3′) [19]. For species specific
qPCR were used following primer pairs: Bbif1 (5′-CCACATGATCGCATGTGATTG-3′) and
Bbif2 (5′-CCGAAGGCTTGCTCCCAAA-3′) for B. bifidum species [29], Bbre1 (5′-CCGG
ATGCTCCATCACAC-3′) and Bbre2 (5′-ACAAAGTGCCTTGCTCCCT-3′) for B.breve species [40],
Blon1 (5′-TTCCAGTTGATCGCATGGTC-3′) and Blon2 (5′-GGGAAGCCGTATCTCTACGA-3′) for
B. longum.
3.4. Bifidobacterium Strain Isolation From Mothers’ Caecum
The collected caecum of the mothers was homogenized and serial dilutions (1:10) were performed.
All dilutions were cultivated on MRS agar (Scharlau Chemie, Barcelona, Spain) supplemented with
0.05% (w/v) L-cysteine hydrochloride (Sigma-Aldrich) and 50µg/mL mupirocin (Delchimica, Napoli,
Italy). After 48h of incubation in an anaerobic atmosphere (2.99% H2, 17.01% CO2 and 80% N2) in a
chamber (Concept 400, Ruskin), morphologically distinct colonies were selected and cultivated in MRS
broth (Scharlau Chemie, Barcelona, Spain) supplemented with 0.05% (w/v) L-cysteine hydrochloride
(Sigma-Aldrich). Subsequently, after overnight growth, bacterial DNA was extracted as described
previously [41]. The identification of specific strains was obtained using a PCR approach based on
strain-specific primers (see above).
3.5. Bifidobacterial ITS PCR Amplification and Sequencing
Following bacterial DNA extraction from caecal samples of mothers and puppies, partial ITS
sequences were amplified using primer pair Probio-bif_Uni/Probio-bif_Rev, which targets the spacer
region between the 16S rRNA and 23S rRNA genes within the ribosomal RNA (rRNA) locus [36].
At the same time, we prepared a mock community (Mock Bifidobacterial Community), consisting
of a pool of known concentrations of 11 different Bifidobacterium strains prepared by combining
equal concentration of bacterial DNA. The DNA from the mix was diluted to produce a final DNA
concentration of 2 ng/µL, and 4 µL of these dilutions were used in each PCR reaction using primer
pair Probio-bif_Uni/Probio-bif_Rev. Illumina adapter overhang nucleotide sequences were added to
the partial ITS amplicons, which were further processed employing the 16S Metagenomic Sequencing
Library Preparation Protocol (Part #15044223 Rev. B–Illumina). The library preparation was performed
as described above for the 16S rRNA microbial profiling analyses.
Following sequencing, the.fastq files were processed using a custom script based on the QIIME
software suite [42]. In order to reconstruct the complete Probio-bif_Uni / Probio-bif_Rev amplicons,
the paired-end read pairs were assembled. Quality control retained sequences with a length between
100 and 400 bp and mean sequence quality score of >20, while sequences with homopolymers >7 bp in
length and mismatched primers were removed. ITS Operational Taxonomic Units (OTUs) were defined
at 100% sequence homology using uclust software [43]. All reads were classified to the lowest possible
taxonomic rank using QIIME2 [42,44] and a reference dataset, consisting of an updated version of the
bifidobacterial ITS database [36].
3.6. Data Deposition
Raw sequences of the bifidobacterial ITS profiling experiments are accessible through SRA study
accession numbers PRJNA556137.
4. Conclusions
This study was aimed to investigate the DNA bifidobacterial transmission from female rats to their
corresponding pups through a vertical route. Notably, the efficiency/yield of these DNA transmission
events may be influenced by the co-presence of different bifidobacterial strains. The above results
confirm previous genus-level overviews [37] and underpin the notion that bifidobacterial transmission
is characterized by the development of extensive microbe-microbe co-operation [7,11,33]. In fact,
our data suggest that bifidobacterial communities have established co-operative behavior between
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co-colonizers, acting as evolutionary drivers in the mammalian gut microbiota. This assumption is
further reinforced by previous studies that have described the occurrence of cross-feeding between
specific bifidobacterial species [7,33]. In addition, our findings have provided preliminary insights
about the existence of possible bifidobacterial colonization at the preterm level. Nevertheless, the lack
of any data about the viability of PRL2010 cells cannot fully support the existence of fetal colonization
of bifidobacteria, and further experiments will be needed in order to investigate this intriguing route
of bacterial colonization.
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